Meet the Inflamax Research team
Meet the Inflamax Research team at WAC 2018 AAAAI WAO Joint Congress by American Academy of Allergy, Asthma, and Immunology & World Allergy Organization in Orlando, FL...Learn More
Dr. Chirag Shah at 12th Biosimilars Congregation 2018.
Dr. Chirag Shah, Director - Late Phase Trials will speak on "Regulatory considerations in Clinical Study Design of Biosimilars" at 12th...Learn More
NJ Tobacco Research Amendment Signed into Law!
Today, after 24 months of Hill Top / Inflamax Research working with legislators and special interest groups in New Jersey,Governor Chris Christie signed Assembly Bill A39...Learn More
Cliantha Research acquires Inflamax Research
Cliantha Research is proud to announce the acquisition of Inflamax Research. Inflamax has locations in Toronto, ON, Neptune, NJ and Newark, NJ...Learn More
Cliantha at DCAT 2017
Cliantha will be attending DCAT once again. Our senior leaders Naveen Sharma, John Capicchioni and Rahul Nijhawan will be in attendance. They are looking forward to meeting with you...Learn More
Hill Top Research has successfully completed FDA inspection
USFDA inspection of Hill Top Research Inc. was conducted at our St. Petersburg, Florida site from Feb 22, 2017 to Mar 01, 2017...Learn More
Lecture & Panel Discussion at APA-India 2017
Dr. Shaifali Gupta, Laboratory Director, spoke on Biosimilars Bioanalysis: Challenges and Solutions at APA- India 2017 on 21 February’17 at Ahmedabad, India...Learn More
Poster presentation at APA-India 2017
Mr. Soumen Chakraborty presented a poster on “Bioanalytical Challenges in developing and validating a biomarker assay...Learn More